China's Shenzhen Hepalink takes 10% stake in ProMetic; signs research deal

China's Shenzhen Hepalink takes 10% stake in ProMetic; signs research deal
ProMetic Life Sciences Inc. (TSX:PLI) is moving to expand its presence in Asia through strategic agreements that will see China's Shenzhen Hepalink Pharmaceutical Co. Ltd. take a 10 per cent interest in the company. Quebec-based ProMetic said Tuesday …
Read more on CanadianBusiness.com

Leave a Reply

Submit Your Photo Of Shenzhen

Share A Story/ Photo of your city!

Sign in with:
Title:
Text: (Type story here, it will show as text under the photo)
Picture: (will be re-sized automatically)
Tags: (add comma separated tags here)

 

You agree to these terms & conditions when posting!

English + no HTML please. We email you once your post is live.

Advanced submission/ Mobile users